Vitasora Health Limited
VHLUF
$0.01
-$0.05-91.39%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 755.40K | 753.00K | 692.10K | 677.80K | 304.00K |
| Total Other Revenue | 179.80K | 179.20K | 0.00 | 0.00 | 199.20K |
| Total Revenue | 935.20K | 932.20K | 692.10K | 677.80K | 503.10K |
| Cost of Revenue | 25.00K | 25.00K | -87.70K | -85.90K | 98.90K |
| Gross Profit | 910.10K | 907.20K | 779.80K | 763.60K | 404.30K |
| SG&A Expenses | 2.37M | 2.37M | 2.80M | 2.74M | 1.55M |
| Depreciation & Amortization | 214.30K | 213.60K | 9.40K | 9.30K | 9.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.62M | 2.61M | 2.76M | 2.71M | 1.69M |
| Operating Income | -1.68M | -1.68M | -2.07M | -2.03M | -1.19M |
| Income Before Tax | -1.68M | -1.68M | -2.07M | -2.03M | -1.19M |
| Income Tax Expenses | -- | -- | 400.00 | 400.00 | -- |
| Earnings from Continuing Operations | -1.68M | -1.68M | -2.07M | -2.03M | -1.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.68M | -1.68M | -2.07M | -2.03M | -1.19M |
| EBIT | -1.68M | -1.68M | -2.07M | -2.03M | -1.19M |
| EBITDA | -1.67M | -1.67M | -2.06M | -2.02M | -1.18M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.74B | 1.74B | 1.58B | 1.58B | 1.21B |
| Average Diluted Shares Outstanding | 1.74B | 1.74B | 1.58B | 1.58B | 1.21B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |